Next, we conducted a subgroup analysis by clinicopathologic features (tumor grade, tumor stage and clinical grade) and found that exosomal PTENP1 levels gradually decreased with the deterioration of clinicopathologic features. This evidence concerns the gene PTENP1 and neoplasm.